Legal Disclaimer

This page provides general legal orientation for United Arab Emirates, not legal advice. Regulations change frequently. Always verify current rules with DHA and consult a qualified professional.

Peptide Legal Status in United Arab Emirates

Moderate

The UAE regulates pharmaceuticals through the Ministry of Health and Prevention (MOHAP) federally and the Dubai Health Authority (DHA) in Dubai. GLP-1 agonists are available by prescription from licensed physicians. The UAE has a significant medical tourism industry, and peptide therapies are often accessed through private clinics. Telehealth prescribing is regulated and evolving.

Regulator

DHA (Dubai Health Authority) / MOHAP (Ministry of Health and Prevention) — Official website

Key Facts

Regulatory Stance
moderate
Compounding Allowed
Yes
Telehealth Prescribing
Yes

Compounding Pharmacy Rules

Compounding pharmacies operate under MOHAP/DHA licensing. The UAE follows international GMP standards. Compounded preparations require valid prescriptions. The regulatory framework for compounding is less mature than in the US or EU, and enforcement varies.

Telehealth Prescribing

DHA has issued telehealth standards (Circular CIR-2025-00000212). Licensed telemedicine providers may prescribe within their scope. Cross-emirate prescribing rules vary. International telehealth services face regulatory complexity.

Peptide Categories in United Arab Emirates

Approved

Semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), liraglutide (Saxenda) — registered and available by prescription.

Research / Unapproved

BPC-157, TB-500, GHRPs — not registered. Sale of unregistered medicines is prohibited. Enforcement intensity varies between emirates. Some peptides circulate through unregulated channels despite restrictions.

Banned / Restricted

Unregistered therapeutic products. The UAE maintains a controlled substances list. Importation of medicines requires MOHAP approval.

Key Legislation

  • Federal Law No. 8 of 2019 on Medical Products
  • Cabinet Resolution No. 38 of 2020 on Medical Products
  • DHA telehealth standards

Peptides in United Arab Emirates: FAQ

Sources

Peptide Laws in Other Countries

United KingdomCanadaAustraliaEuropean UnionSingaporeNew ZealandGermanyNetherlandsFranceSpainHong KongJapanSouth Korea